Cannabis is one of the most widely used drugs in the world. In 2020, France had 18 million subjects aged 18-64, who had it, ie 46% of this age group, while in Europe the proportion is 27%. Repeated use is especially discussed, which for medical purposes or rather involuntarily is called “for rest”. It is in this context that on January 14, 2020, the National Assembly established a parliamentary mission, which is responsible for studying the impact of the regulations and its use, according to three goals: “Therapeutic” hemp, tested with five instructions. “Wellness” hemp in the form of food supplements, herbal teas, cosmetics, electronic liquids. “Rest” hemp.
Both drugs are already approved
Hemp or cannabis contains two main constituents: tetrahydrocannabinol or THC և cannabidiol or CBD. As for the use of cannabis in therapy, several drugs are already authorized by the European Medicines Agency և have…
Source: Le Figaro
